The Trump administration has finalized a deal with drugmaker AbbVie to cut the cost of certain medicines, marking the latest ...
Lower risk for foot disease driven by lower risk for neuropathy for new users of SGLT-2 inhibitors versus GLP-1 receptor agonists.
Zacks Investment Research on MSN
Novo Nordisk soars 19% in a month: How should you play the stock?
Novo Nordisk NVO shares have surged 18.8% in the past month. The stock price gain was primarily induced by the ...
In the third quarter of 2025, Mirador closed a $250 million Series B financing, bringing total capital raised to more than $650 million since the company launched in March 2024. The proceeds enable ...
Nearly 1.5 million Americans and nearly 5% of women over the age of 55 have rheumatoid arthritis (RA), an incurable ...
Both upadacitinib (Rinvoq) and adalimumab (Humira) are proven effective in rheumatoid arthritis (RA) and psoriatic arthritis ...
SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback